FDA Backs Off on Regulation of Fecal Transplants

Federal regulators are dropping plans to tightly control a procedure that is becoming increasingly popular for treating people stricken by life-threatening infections of the digestive system.

The College believes the decision by FDA to clarify IND requirements and enforcement in relation to fecal microbiota transplantation to treat refractory C. difficile-associated diarrhea is an important step in right direction. (6/18)